Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03185351Phase 2Completed
Phase 2, randomised trial of midazolam in pain (3 arms), sponsored by Assiut University. Primary endpoint: Numerical rating pain scale at 24 hours. Started Jun 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03185351.